Provided by:
Cardiology Grand Rounds
Academic Year 2014-2015
“Role of the “periphery” in Heart Failure in Preserved Ejection Fraction”
April 2, 2015
7:30 – 8:30 AM
11-146 Smilow Center for Translational Research
Julio A. Chirinos, MD, PhD, FAHA
Assistant Professor of Medicine
Director, Cardiovascular Phenotyping Unit
Clinical Translational Research Center
University of Pennsylvania
Target Audience
This program has been designed for departmental/institutional faculty, fellows, residents, medical students, nurses, and
QA/CEQI personnel in the medical specialties of cardiology, CT surgery, radiology, cv imaging, and medicine, biology
engineering, pharmacology, and physiology.
Educational Objectives
After completing this activity, participants should be able to:
 Describe evidence supporting the latest treatment for cardiac conditions (ie., interventional procedures such as
cardiac catheterization, cardiac biopsies, electrophysiologic studies), noninvasive cardiac procedures and clinical
cardiology therapy
 Recognize the importance of system-based practices that explicitly depict the larger context and system of health
care by stressing the importance of collaborative efforts involving physicians and ancillary staff for safety and
quality improvements
 Assess patient care through discussing medical errors, complications and unanticipated outcomes
 Improve practice through reviewing records, specifics and revisiting errors to gain insight without blame or derision
 Review experimental data from translational and clinical studies with the potential to influence practice
 Assess the results of clinical trials from a regional and national point of view
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA
Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Lynn Radnich
215-662-3140, lynn.radnich@uphs.upenn.edu
Check your CME online at www.penncmeonline.com
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to
control the content of an educational activity to disclose to the learners all relevant financial relationships that they have
with any commercial interest that provides products or services that may be relevant to the content of this continuing
medical education activity. For this purpose we consider relationships of the person involved in the CME activity to
include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from
involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in
improving medical practice, are based on valid content, and are independent of control from commercial interests and
free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure
information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest
relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically
rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic,
Director of CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have
no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests
related to the content of this educational activity:
PLANNING COMMITTEE MEMBER NAME
DANIEL M. KOLANSKY, MD
MARIA A. GUERTTY, MD, PHD
PRESENTER NAME
The following individuals have reported the listed relevant financial relationships with commercial interests related to
the content of this educational activity.
PRESENTER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
Julio A. Chirinos, MD, PhD
OPKO HealthCare, Bristol Myers Squibb
Fukuda Denshi, Highpoint Pharmaceuticals
NIH, Veterans Affairs Admin
American College of Radiology Network
Consultant
Consultant
Research Funding
Research Funding
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary,
royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership
interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as
employment, management position, independent contractor (including contracted research), consulting, speaking and teaching,
membership on advisory committees or review panels, board membership, and other activities from which remuneration is received
or expected
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
JULIO A. CHIRINOS, MD, PHD
PRODUCT
CALCIUM CHANNEL BLOCKERS
INORGANIC NITRATE
ENDOTHELIN RECEPTOR ANTAGONISTS
ORGANIC NITRATES/HYDRALAZINE
INVESTIGATIONAL AND/OR OFF-LABEL USE
USE IN HFPEF
USE IN HFPEF
USE IN HFPEF
USE IN HFPEF